Ipsen to acquire Kartos Therapeutics for up to $1.75 billion
Investing.com Gold reports: Ipsen to acquire Kartos Therapeutics for up to $1.75 billion. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Ipsen to acquire Kartos Therapeutics for up to $1.75 billion. Full body text was unavailable at ingest time, so this brief is based on headline context.